1. Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers. (October 2022) Authors: Wee, S.; Ye, M.; Lo, Y.; Hansbury, M.; Shin, N.; Weber, M.; Roman, V.; Huo, L.; Skaggs, H.; Drake, K.; Kapilashrami, K.; Stump, K.; Yang, J.; Chand, S.; Timmers, C.; Hummel, J.; Ye, Y.; Zhang, G.; Yang, Y.O.; Covington, M. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0100 MOLECULAR PROFILING OF PERIPHERAL IMMUNE CELL SUBSETS IN PATIENTS WITH RHEUMATOID ARTHRITIS. (2nd June 2020) Authors: Taylor, P. C.; Liu, J.; Zhuo, L.; Tian, Y.; Snyder, T.; Kim, C.; Kheradpour, P.; Drake, K.; Kim, S.; Hawtin, R. E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Thermospheric damping response to sheath‐enhanced geospace storms. Issue 7 (15th April 2013) Authors: Knipp, D.; Kilcommons, L.; Hunt, L.; Mlynczak, M.; Pilipenko, V.; Bowman, B.; Deng, Y.; Drake, K. Journal: Geophysical research letters Issue: Volume 40:Issue 7(2013:Apr.) Page Start: 1263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗